BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mannan A, Garg N, Singh TG, Kang HK. Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury. Neurochem Res 2021. [PMID: 34282491 DOI: 10.1007/s11064-021-03402-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kumar AP, Mandal S, P P, Faizan S, Kumar BRP, Dhanabal S, Justin A. Rational design, molecular docking, dynamic simulation, synthesis, PPAR-γ competitive binding and transcription analysis of novel glitazones. Journal of Molecular Structure 2022;1265:133354. [DOI: 10.1016/j.molstruc.2022.133354] [Reference Citation Analysis]
2 Vishwakarma S, Singh S, Singh TG. Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis. Mol Biol Rep 2021. [PMID: 34751915 DOI: 10.1007/s11033-021-06896-8] [Reference Citation Analysis]
3 Rayner MLD, Healy J, Phillips JB. Repurposing Small Molecules to Target PPAR-γ as New Therapies for Peripheral Nerve Injuries. Biomolecules 2021;11:1301. [PMID: 34572514 DOI: 10.3390/biom11091301] [Reference Citation Analysis]
4 Usman H, Tan Z, Gul M, Rashid S, Ali T, Shah FA, Li S, Li JB. Identification of novel and potential PPARγ stimulators as repurposed drugs for MCAO associated brain degeneration. Toxicol Appl Pharmacol 2022;:116055. [PMID: 35550883 DOI: 10.1016/j.taap.2022.116055] [Reference Citation Analysis]
5 Yu S, Ren J, Lv Z, Li R, Zhong Y, Yao W, Yuan J. Prediction of the endocrine-disrupting ability of 49 per- and polyfluoroalkyl substances: In silico and epidemiological evidence. Chemosphere 2021;290:133366. [PMID: 34933031 DOI: 10.1016/j.chemosphere.2021.133366] [Reference Citation Analysis]
6 Sanjay, Sharma A, Lee HJ. Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders. Biomedicines 2021;9:1914. [PMID: 34944727 DOI: 10.3390/biomedicines9121914] [Reference Citation Analysis]